Vaccine Info

Measles Vaccines March 2023

Authored by
Last reviewed
March 12, 2023
Fact checked by
Robert Carlson, MD

Measles Vaccines March 2023

Measles vaccination programs started in the U.S. in 1963 and will continue in 2023. As of March 2023, the U.S. Centers for Disease Control and Prevention (CDC) published the measles vaccination schedules for children, adults, and international travelers. The U.S. Food and Drug Administration (FDA) approved on March 6, 2023, the addition of the intramuscular route of administration for M-M-R®II and ProQuad®.

The CDC reported on January 13, 2023, nationally, 2-dose MMR coverage was 93.5% (range = 78.0% [Alaska] to 98.0% [New York]) during the 2020–21 school year.

The U.S. FDA recently approved the Priorix vaccine to prevent measles, mumps, and rubella (MMR) in individuals one year and older. The U.S. CDC stated on November 18, 2022, the Priorx and M-M-R II® vaccines are considered fully interchangeable, including for all off-label recommended uses. The CDC's MMR Vaccine Work Group presented: Overview of Measles by Ms. Lynn Bahta and Overview of GSK's Priorix MMR Vaccine by Remon Abu-Elyazeed, MD, Ph.D., US Vaccines Medical and Clinical Affairs. 

Measles Vaccines 2023

M-M-R®II - The Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II) is approved by the U.S. FDA for use in people 12 months and older. Two doses of the MMR vaccine are about 97% effective at preventing measles, and one dose is about 93% effective.

Proquad® - Children ages 1 through 12 may also get the Measles, Mumps, Rubella, and Varicella Virus Vaccine (MMRV). This FDA-approved vaccine also prevents chickenpox.

Priorix - Is licensed in the USA and over 100 countries for use in individuals aged 9 or 12 months, according to a 1- or 2-dose schedule, depending on the country. Priorix protects people against MMR. The CDC vaccine committee recommends PRIORIX according to the existing MMR vaccine schedules and off-label uses as an option to prevent MMR.

Tresivac - This vaccine is available in India to prevent measles, mumps, and rubella. Serum Institute of India Ltd is the manufacturer.

Shanghai Institute of Biological Products released about 42 million MMR doses in China in 2020. 

Bio-MMR vaccine is offered in Brazil.

India MMR vaccine is offered to children.

MeasBio® (Biovac) in South Africa.

Measles Vaccine Price

According to the U.S. CDC, measles vaccine prices range from $87.31 to $250.02 as of July 2022. Additional measles vaccine prices and discount information are posted at InstantRx™.

Measles Vaccine News 2023

February 14, 2023 - The U.S. CDC updated its Global Measles Outbreaks list, indicating India had confirmed about 32,000 measles cases last year.

February 4, 2023 - The Columbus, Ohio Department of Health tweeted the multi-month measles outbreak was declared ended.

January 16, 2023 - Jefferson County Public Schools in western Kentucky is conducting measles vaccination clinics at several schools for about 10,000 under-vaccinated students.

Measles Outbreaks 2023

According to the CDC, the U.S. has maintained its measles-free elimination status for over twenty years. Measles outbreak news for 2023 is posted at this Vax-Before-Travel link.

Clinical Trials

No clinical trials found